Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT00859092
Other study ID # 07-12-FB-0305
Secondary ID
Status Completed
Phase Phase 2
First received March 9, 2009
Last updated March 7, 2012
Start date March 2008
Est. completion date September 2010

Study information

Verified date March 2012
Source Eastern Virginia Medical School
Contact n/a
Is FDA regulated No
Health authority United States: Institutional Review Board
Study type Interventional

Clinical Trial Summary

Swallowing dysfunction and delay of oral feeding skills in premature infants significantly delay discharge from the hospital. Thickening oral formula or breast milk feeds with commercial thickeners and rice cereal has been used in some nurseries with the goal of promoting development of adequate feeding skills. The objective of this pilot study is to examine the effect of thickened feeds on premature infants with oral feeding difficulties due to dysfunction secondary to immature swallowing.

Hypotheses:

- Thickened feeds will lead to a reduction in symptoms secondary to immature swallowing in 32-40 weeks gestational age infants when compared to non-thickened feeds

- Thickened feeds will promote transition to hospital discharge.


Recruitment information / eligibility

Status Completed
Enrollment 15
Est. completion date September 2010
Est. primary completion date June 2009
Accepts healthy volunteers No
Gender Both
Age group N/A to 3 Months
Eligibility Inclusion Criteria:

1. apneas and bradycardias with oral feedings

2. oxygen desaturations with oral feedings

3. excessive coughing or gagging with oral feedings

Exclusion Criteria:

1. less than 32 weeks adjusted gestational age

2. greater than 40 weeks adjusted gestational age

Study Design

Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Crossover Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Dietary Supplement:
Simply Thick
Simply Thick® added to each bottle of formula or beast milk to create nectar or honey consistency

Locations

Country Name City State
United States Sentara Norfolk General Hospital Norfolk Virginia

Sponsors (1)

Lead Sponsor Collaborator
David Oelberg, M.D.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Elimination of symptoms associated with immature swallowing 2 days No
Secondary Promotes transition to discharge from hospital one week No
See also
  Status Clinical Trial Phase
Active, not recruiting NCT04597177 - SW-IMRT Versus ST-IMRT in the Treatment of Head and Neck Cancer N/A